Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 30, 2015LeukemiaOpen Access

NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

KBKonstantin ByrgazovOncopeptides (Sweden)RKRenate KastnerKlinik für FrauenheilkundeMGMaria W. GórnaUniversity of Warsaw

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Byrgazov et al. (2015) studied this question.

synapsesocial.com/papers/69d56ed575589c71d767d6cfhttps://doi.org/10.1038/leu.2016.250
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib2014 · 143 citations
  2. 2Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase2004 · 640 citations
  3. 3Optimization of a Potent Class of Arylamide Colony-Stimulating Factor-1 Receptor Inhibitors Leading to Anti-inflammatory Clinical Candidate 4-Cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)2011 · 33 citations
  4. 4Non-ATP Competitive Protein Kinase Inhibitors2010 · 124 citations
  5. 5Functional characterisation of different MLL fusion proteins by using inducible Sleeping Beauty vectors2014 · 35 citations